This bill amends Section 317K of the Public Health Service Act to reauthorize and update federal support for State-based maternal mortality review committees. It clarifies committee membership and data-coordination authorities, directs HHS (through CDC and consulting with HRSA) to disseminate maternal mortality prevention best practices to key clinical and quality networks, and extends the program’s authorization period.
For health officials and compliance officers, the bill tightens the link between review committees and death-certification processes, mandates regular federal dissemination of prevention practices to hospitals and perinatal quality actors, and increases the federal authorization level for the program for the coming five fiscal years — changing how states, hospitals, and certifiers will need to coordinate around maternal death data and prevention efforts.
At a Glance
What It Does
Amends 42 U.S.C. 247b–12 to (1) insert explicit clinical representation on review committees, (2) expand committees’ authority to coordinate with death certifiers — including amending cause-of-death entries — and (3) require the CDC, with HRSA input, to disseminate best practices on maternal mortality prevention to hospitals, State professional societies, and perinatal quality collaboratives at least once per year. It also replaces prior authorization levels with $100 million authorized per fiscal year for FY2025–FY2029.
Who It Affects
State maternal mortality review committees, hospital systems and obstetric units, State medical and professional societies, perinatal quality collaboratives, death certifiers (coroners/medical examiners/state vital records offices), and federal public-health agencies (CDC and HRSA).
Why It Matters
The measure tightens the operational link between review committees and death-certificate accuracy while creating a recurring federal vehicle for sharing prevention practices with clinicians and quality networks. That combination aims to turn review findings into standardized clinical guidance and more accurate vital statistics — but also shifts administrative and legal burdens onto certifiers and state systems.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill changes the statutory language governing maternal mortality review committees so that clinical membership is explicitly anchored to obstetric practice: the statute now makes clear that clinical specialties on the committee include obstetricians and gynecologists. Practically, that reduces ambiguity when states assemble multidisciplinary teams and signals congressional intent that OB-GYN clinical expertise be present in reviews.
The text also alters the committee’s data-use language. One phrase that previously read as permissive is recast to rely on data “if available,” which lowers a formal availability test and gives committees more explicit latitude to use medical and administrative records when those records exist.
In parallel, the law adds a direct coordination duty between committees and death certifiers: committees are now authorized to work with certifiers to improve death-record collection and quality, explicitly including the possibility of amending cause-of-death information on a death certificate where appropriate. That is a notable operational shift: it recognizes committee findings as actionable inputs to vital records, rather than leaving certificate updates solely to certifiers’ initial determinations.On the prevention side, the bill requires the CDC — consulting with HRSA — to assemble and share best practices on preventing maternal mortality and morbidity.
The statute names recipients (hospitals, State professional society groups, and perinatal quality collaboratives) and sets an annual minimum frequency for dissemination. The guidance must also reflect best practices identified through related federal maternal health programs, so the CDC’s product is intended to harmonize across federal initiatives rather than sit apart as an isolated document.Administratively, the bill renames two adjacent subsections to preserve statutory order and replaces the prior authorized funding levels with a new authorization that spans five fiscal years.
The practical outcome is more predictable federal support for state review work and dissemination activities, but the text does not create new enforcement tools or grantmaking conditions tied to performance metrics; it raises authorization levels and clarifies duties without prescribing specific state-level compliance benchmarks.
The Five Things You Need to Know
The bill inserts the phrase “including obstetricians and gynecologists” into the statutory list of clinical specialties for maternal mortality review committees.
It changes a data-use qualifier to “if available,” expanding committee discretion to use medical and administrative records where present.
The statute explicitly authorizes committees to coordinate with death certifiers to improve death records and to amend cause-of-death information on death certificates, as appropriate.
The CDC, in consultation with HRSA, must compile and disseminate maternal mortality prevention best practices to hospitals, State professional societies, and perinatal quality collaboratives at least once per fiscal year.
The bill replaces prior authorization language with a new authorization of $100,000,000 per fiscal year for each of fiscal years 2025 through 2029.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Establishes the Act’s short title as the “Preventing Maternal Deaths Reauthorization Act of 2025.” This is procedural but important for citation and for packaging the subsequent statutory amendments under a single, searchable name.
Clarifying committee composition and data authority
Subsection 317K(d)(1)(A) is amended to add “including obstetricians and gynecologists” to the list of clinical specialties that should serve on maternal mortality review committees. That amendment removes ambiguity about whether OB-GYNs are required or merely optional members. Subsection 317K(d)(3)(A)(i) has two targeted edits: one replaces a permissive availability phrase with “if available,” and another expands the committee’s role to explicitly include coordinating with death certifiers to improve death record collection and quality — including amending cause-of-death fields on certificates “as appropriate.” Practically, this provision creates a statutory route for committees to influence vital records when review findings indicate a certificate correction is warranted.
Annual dissemination of prevention best practices
The bill inserts a new subsection directing the Secretary, through the CDC and in consultation with HRSA, to disseminate best practices on preventing maternal mortality and morbidity. The recipients named in the statute are hospitals, State professional society groups, and perinatal quality collaboratives; the statute requires dissemination at least once per fiscal year and instructs that the guidance reflect best practices identified across relevant federal maternal health programs. Implementation will require the CDC to curate and translate review findings and federal program outputs into usable clinical and quality-improvement material.
Technical renumbering to preserve statutory structure
The bill redesignates the existing subsections (previously e and f) to accommodate the new subsection. This is a clerical change but ensures the statute reads coherently after insertion of the new dissemination duty and preserves cross-references elsewhere in the Public Health Service Act.
Extension and increase of authorized funding
The bill replaces the prior authorization figures for section 317K with an authorization of $100,000,000 for each fiscal year from 2025 through 2029. That change substantially increases the program’s authorized federal funding and extends the authorization window, providing multi-year certainty for states and federal agencies to plan and scale review and dissemination efforts. The statute does not allocate the funds in detail or add new conditionality tied to performance metrics.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- State maternal mortality review committees — Gain clearer statutory authority to include OB-GYN clinicians and to engage with death certifiers, which can improve case reviews and the accuracy of official death records.
- Hospitals and obstetric units — Receive annual, centralized CDC guidance informed by federal programs and reviews, which can shorten the time between review findings and clinical-quality interventions.
- Perinatal quality collaboratives and State professional societies — Are designated recipients of best-practice dissemination, improving access to federally curated prevention strategies and creating a clearer pathway to implement evidence-based protocols.
Who Bears the Cost
- State vital records offices, coroners, and medical examiners — Face new coordination duties and potential legal/process work to amend cause-of-death entries, which may require staff time, procedural changes, or new legal reviews.
- Hospitals and health systems — Will need to review, adapt, and implement annually disseminated guidance, which may require investment in training, data systems, and clinical process changes.
- Federal agencies (CDC and HRSA) — Take on ongoing operational duties (compiling, consulting, and annually disseminating best practices) and will need resources and staff capacity to maintain that work alongside the expanded authorization.
Key Issues
The Core Tension
The bill balances two legitimate goals—making maternal death data more accurate and translating review findings into preventable clinical practice—against practical constraints: state-controlled death-certificate law, uneven local capacity to implement guidance, and the absence of new enforcement or accountability tools. Improving data and care requires authority and resources; but expanding committee influence over vital records and relying on voluntary dissemination leaves unresolved how to convert federal support into uniform, enforceable improvements across diverse state systems.
The bill strengthens the link between review committees and vital records in ways that raise practical and legal questions. Authorizing committees to coordinate with death certifiers and to amend cause-of-death information creates a pathway to correct misclassified maternal deaths, but it collides with a patchwork of state laws about who may alter death certificates and what procedural safeguards (e.g., coroner findings, toxicology results, or judicial review) are required.
States will need to reconcile committee recommendations with existing statutory processes for certificate amendment, and some states may require legislative or administrative rule changes to operationalize the new federal encouragement.
The statute requires annual dissemination of best practices but stops short of creating enforcement mechanisms or performance metrics for states or hospitals. That design reduces federal intrusiveness but also risks uneven uptake: larger systems and proactive collaboratives are likely to adopt CDC guidance quickly, while under-resourced hospitals and smaller jurisdictions may not.
The sizable increase in authorized funding gives HHS more capacity, but the bill does not specify how funds will be apportioned, whether funds are grants or cooperative agreements, or whether there will be accountability tied to improved maternal outcomes or better death-record accuracy. Finally, compiling “best practices” across federal programs creates harmonization benefits but also raises the risk that conflicting recommendations from different programs will need to be reconciled, which could delay timely guidance.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.